News and Trends 2 Feb 2023
Recurv Pharma receives funding for cancer therapy development
Recurv Pharma Inc. is receiving up to $24 million in funding from TVM Capital Life Science through its TVM Life Science Innovation II SCSp fund. Recurv Pharma plans to develop…